Bioregulator Peptides (Khavinson Peptides)
Bioregulatory Peptide ClassclinicalAlso known as: Khavinson Peptides, Cytogens, Cytomax, Short Bioregulatory Peptides, Russian Peptide Bioregulators
A class of ultra-short (2-4 amino acid) tissue-specific peptides developed by Prof. Vladimir Khavinson that regulate gene expression in target organs, used in Russian medicine for anti-aging and organ-specific rejuvenation.
Overview
Bioregulator peptides are a unique class of short peptide sequences (typically 2-4 amino acids) developed over 40+ years of research by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. The core concept is that each organ produces specific short peptides that regulate its own gene expression, and that supplementing these peptides can restore youthful function to aging tissues. The most well-known bioregulators include Epithalon/Epitalon (pineal gland/telomerase), Thymalin (thymus/immune), Vilon (immune), Livagen (liver), Prostamax (prostate), Cortagen (brain cortex), Cardiogen (heart), Chonluten (lungs), Vesugen (blood vessels), and Pancragen (pancreas). In Russia and some European countries, several of these are registered pharmaceuticals. The underlying theory — that short peptides can penetrate cell nuclei and directly interact with DNA to modulate gene expression — is supported by Khavinson's extensive publication record (800+ papers) but remains controversial in Western medicine. Many bioregulators are available as oral supplements (Cytogens/Cytomax brands) as well as injectable forms.
Mechanism of Action
Bioregulator peptides are proposed to work through a distinctive mechanism: (1) Due to their extremely small size (2-4 amino acids), they can penetrate cell membranes and nuclear envelopes without receptor-mediated transport; (2) Once in the nucleus, they interact with specific DNA sequences, particularly in promoter regions, to modulate gene expression by altering chromatin structure and transcription factor accessibility; (3) Each peptide has tissue specificity — Epithalon targets pinealocytes, Thymalin targets thymocytes, etc.; (4) They are proposed to restore gene expression patterns toward a more youthful state, effectively 'resetting' age-related epigenetic changes; (5) Some, like Epithalon, have demonstrated measurable effects such as telomerase activation and melatonin production restoration. The overarching theory is that aging involves progressive loss of peptide bioregulation, and supplementation can partially reverse this decline.
Molecular Formula
Various (each bioregulator has its own sequence)
Molecular Weight
200-500 Da (typical range for di- to tetrapeptides)
Sequence
Key sequences: Epithalon (Ala-Glu-Asp-Gly), Thymalin (mixture), Vilon (Lys-Glu), Livagen (Lys-Glu-Asp-Ala), Cortagen (Ala-Glu-Asp-Pro), Cardiogen (Ala-Glu-Asp-Arg), Chonluten (Glu-Asp-Gly), Pancragen (Lys-Glu-Asp-Trp)
Dosage Protocols
Dose Range
1 capsule – 2 capsules
Frequency
1-2x daily with meals
Route
oral
Cycle Length
10-30 days, repeated 2-3 times per year
Oral bioregulators (Cytogens) are taken in short courses. Multiple organ-specific bioregulators can be taken simultaneously. Typically done seasonally — e.g., spring and autumn courses.
Source: Khavinson protocols and manufacturer guidelines
🧮 Personalized Dosage Calculator
💰 Estimated Pricing
Typical Supply
20mg capsules, 60ct
Last Updated
2026-02
Khavinson peptide bioregulators (Epithalamin, Thymalin, etc.). Available from Russian/European sources. Per-organ formulas.
⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.
Side Effects
| Effect | Severity |
|---|---|
| Mild GI discomfort | mild |
| Injection site soreness | mild |
| Fatigue during course | mild |
Pros & Cons
Backed by 40+ years of research and 800+ publications from Khavinson's institute
Extremely clean safety profile — no serious adverse events reported across decades of use in Russia
Oral forms available — no injections required for the Cytogens line
Organ-specific targeting allows customized anti-aging protocols for individual health concerns
Short treatment courses (10-30 days) with effects lasting months — not daily lifelong supplementation
Most research published in Russian journals with limited Western peer review or replication
Mechanism of direct DNA interaction by short peptides is controversial and not fully accepted
No FDA approval or recognition — considered alternative/experimental in Western medicine
Quality and authenticity of products outside Russia can be difficult to verify
Effects are subtle and typically require biomarker testing to verify — not dramatic visible results
Research Studies
🩸 Blood Work
No specific bloodwork requirements reported for this peptide. General health panels are always recommended before starting any peptide protocol.
Legal Status
Several are registered pharmaceuticals in Russia. Available as dietary supplements (Cytogens brand) internationally. Not FDA-approved. Available as research peptides from various suppliers. Legal status varies by country.
Readers Also Viewed
Semaglutide
99An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
98A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
97A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
95The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Related Peptides
Semaglutide
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.